Investing in drug safety monitoring could avoid complications -- and save medical costs

(Wolters Kluwer Health) Increased investment in 'pharmacovigilance surveillance' -- systems to proactively monitor safety problems with new medications -- has the potential to avoid harmful drug effects while lowering healthcare costs, according to a study in the June issue of Medical Care. The journal is published by Wolters Kluwer.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2ro3a3E